MyFinsight
Home
Blog
About
Cash and cash
equivalents
$121,747K
(105.36%↑ Y/Y)
Inventory, net
$80,930K
(20.28%↑ Y/Y)
Trade accounts
receivable, net
$58,105K
(9.53%↑ Y/Y)
Prepaid expenses and
other current assets
$13,975K
(134.36%↑ Y/Y)
Total current assets
$274,757K
(48.05%↑ Y/Y)
Intangible Assets Net
Excluding Goodwill
$82,657K
(-11.60%↓ Y/Y)
Goodwill
$22,859K
(0.00%↑ Y/Y)
Operating lease
right-of-use assets
$21,773K
(-2.81%↓ Y/Y)
Other Assets
Noncurrent
$5,025K
(-0.73%↓ Y/Y)
Property and equipment,
net
$4,834K
(-8.52%↓ Y/Y)
Total assets
$411,905K
(23.07%↑ Y/Y)
Accumulated deficit
-$700,174K
(-2.51%↓ Y/Y)
Accumulated other
comprehensive loss
-$10K
(58.33%↑ Y/Y)
Total liabilities and
stockholders' equity
$411,905K
(23.07%↑ Y/Y)
Total stockholders'
(deficit) equity
-$9,734K
(49.58%↑ Y/Y)
Additional paid in capital
$690,432K
(4.03%↑ Y/Y)
Common stockpar value
0.0001, 350,000,000...
$18K
(12.50%↑ Y/Y)
Total liabilities
$421,639K
(19.11%↑ Y/Y)
Total current
liabilities
$189,568K
(99.19%↑ Y/Y)
Debt, net of
unamortized debt issuance...
$188,807K
(-13.64%↓ Y/Y)
Non-current operating lease
liabilities
$30,542K
(-5.85%↓ Y/Y)
Other liabilities
$12,722K
(64.11%↑ Y/Y)
Current portion of
long-term debt
$63,783K
Accrued trade discounts
and rebates
$46,858K
(41.27%↑ Y/Y)
Other accrued
liabilities
$39,706K
(59.02%↑ Y/Y)
Accrued returns reserve
$18,598K
(-5.99%↓ Y/Y)
Accounts payable
$9,337K
(-1.32%↓ Y/Y)
Current operating lease
liabilities
$6,310K
(2.50%↑ Y/Y)
Other current
liabilities
$4,976K
(204.72%↑ Y/Y)
Back
Back
Balance Sheet
Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS)
source: myfinsight.com